Haematologica
(Jun 2022)
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
- Naseema Gangat,
- Jonathan Bleeker,
- Douglas Lynch,
- Horatiu Olteanu,
- Louis Letendre,
- Ayalew Tefferi
Affiliations
- Naseema Gangat
- Division of Hematology, Mayo Clinic, Rochester, MN
- Jonathan Bleeker
- Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
- Douglas Lynch
- Division of Hematology and Hematopathology, Sanford Health, Sioux Falls, SD
- Horatiu Olteanu
- Division of Hematopathology, Mayo Clinic, Rochester, MN
- Louis Letendre
- Division of Hematology, Mayo Clinic, Rochester, MN
- Ayalew Tefferi
- Division of Hematology, Mayo Clinic, Rochester, MN
- DOI
-
https://doi.org/10.3324/haematol.2022.281398
- Journal volume & issue
-
Vol. 107,
no. 10
WeChat QR code